| Rowcaps |
|---|
Rows 1-3, 8: | Show percentage result values that apply to GTREFID=C0. REFID=C0, as shown in the relref dataset, relates this data to the trial set in the first row of Table 1 in the sample report table for study 123. | | Rows 4-7: | Show the four micronucleated cell counts for the observational units with GTREFID from C0-Count1 through C0-Count4, for which their relationship to test conditions (in tx.xpt) and experimental units (in relref.xpt) are shown in the relref dataset. | Rows 9-11, 16: | Show percentage result values that apply to GTREFID=C1250. REFID=C1250, as shown in the relref dataset, relates this data to the trial set in the second row of Table 1 in the sample report table for study 123. | | Rows 12-15: | Show the four micronucleated cell counts for the observational units with GTREFID from C1250-Count1 through C1250-Count4, for which their relationship to test conditions (in tx.xpt) and experimental units (in relref.xpt) are shown in the relref dataset. |
|
| Dataset2 |
|---|
| Row | STUDYID | GNTXAID | DOMAIN | GTREFID | GTSEQ | GTTESTCD | GTTEST | GTCELLEV | GTORRES | GTORRESU | GTCOLSRT | GTSTRESC | GTSTRESN | GTSTRESU | GTDTC |
|---|
| 1 | 123 | MNvit | GT | C0 | 1 | RICC | Relative Increase in Cell Count | 154 | 0 | % |
| 0 | 0 | % | 2022-05-25 | | 2 | 123 | MNvit | GT | C0 | 2 | RCC | Relative Cell Count | 154 | 0 | % |
| 0 | 0 | % | 2022-05-25 | | 3 | 123 | MNvit | GT | C0 | 3 | RPD | Relative Population Doubling | 154 | 0 | % |
| 0 | 0 | % | 2022-05-25 | | 4 | 123 | MNvit | GT | C0-Count1 | 4 | MNCELLSMNCE | Micronucleated Cells | 2205 | 15 | Cells |
| 15 | 15 | Cells | 2022-05-25 | | 5 | 123 | MNvit | GT | C0-Count2 | 5 | MNCELLSMNCE | Micronucleated Cells | 2474 | 13 | Cells |
| 13 | 13 | Cells | 2022-05-25 | | 6 | 123 | MNvit | GT | C0-Count3 | 6 | MNCELLSMNCE | Micronucleated Cells | 2758 | 17 | Cells |
| 17 | 17 | Cells | 2022-05-25 | | 7 | 123 | MNvit | GT | C0-Count4 | 7 | MNCELLSMNCE | Micronucleated Cells | 2669 | 12 | Cells |
| 12 | 12 | Cells | 2022-05-25 | | 8 | 123 | MNvit | GT | C0 | 8 | AVGREL | Average Relative MN FrequencyMNCECE | Micronucleated Cells/Total Cells |
| 0.57 | % |
| 0.57 | 0.57 | % | 2022-05-25 | | 9 | 123 | MNvit | GT | C1250 | 1 | RICC | Relative Increase in Cell Count | 134 | 15.7 | % |
| 15.7 | 15.7 | % | 2022-05-25 | | 10 | 123 | MNvit | GT | C1250 | 2 | RCC | Relative Cell Count | 134 | 13.0 | % |
| 13.0 | 13.0 | % | 2022-05-25 | | 11 | 123 | MNvit | GT | C1250 | 3 | RPD | Relative Population Doubling | 134 | 7.9 | % |
| 7.9 | 7.9 | % | 2022-05-25 | | 12 | 123 | MNvit | GT | C1250-Count1 | 4 | MNCELLSMNCE | Micronucleated Cells | 3266 | 20 | Cells |
| 20 | 20 | Cells | 2022-05-25 | | 13 | 123 | MNvit | GT | C1250-Count2 | 5 | MNCELLSMNCE | Micronucleated Cells | 2190 | 17 | Cells |
| 17 | 17 | Cells | 2022-05-25 | | 14 | 123 | MNvit | GT | C1250-Count3 | 6 | MNCELLSMNCE | Micronucleated Cells | 2758 | 13 | Cells |
| 13 | 13 | Cells | 2022-05-25 | | 15 | 123 | MNvit | GT | C1250-Count4 | 7 | MNCELLSMNCE | Micronucleated Cells | 2714 | 21 | Cells |
| 21 | 21 | Cells | 2022-05-25 | | 16 | 123 | MNvit | GT | C1250 | 8 | AVGREL | MNCECE | Micronucleated Cells/Total Cells Average Relative MN Frequency |
| 0.66 | % |
| 0.66 | 0.66 | % | 2022-05-25 |
|
|